Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03020420
Other study ID # Cicatricell
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2015
Est. completion date December 2020

Study information

Verified date June 2024
Source University of Toledo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study tries to prove that Cicatricell cream significantly reduces scarring with better wound appearance as compared to no treatment.


Description:

At 1st post operative follow up visit, surgical incision(s) will be assessed for healing, after the sutures/staples/steri-strips are removed. To be included in the study the incision must be 5cm or greater. And bilateral incisions as in bilateral mastectomy can be included. The incisions will be divided into two sections, using an imaginary line between top and bottom, or left and right. One side of the imaginary line will have cicatricell cream applied 2 times a day for a minimum of 8 weeks and a maximum 6months. The other side of the imaginary line will remain untreated. In the case of a bilateral incision, as in bilateral breast mastectomy or AAA incisions in the groins, the cream will be applied to one entire incision and the 2nd incision will be untreated. The incision(s) will be its own control group. At the end of the treatment phase the incision(s) will be assessed again to compare the healing.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date December 2020
Est. primary completion date December 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Signed IRB approved, written informed consent. - Patient from 18 to 60 years of age. - Patient who recently underwent a surgery involving linear surgical skin incisions of 5cm or more or patients with two exactly symmetrical separate incisions like bilateral inguinal hernia repair or bilateral mastectomy, CT surgery patients will be included. Exclusion Criteria: - Known skin allergies.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cicatricell Cream
Cream to be applied 2 times a day for 8weeks to 6 months

Locations

Country Name City State
United States UTMC Toledo Ohio

Sponsors (1)

Lead Sponsor Collaborator
University of Toledo Health Science Campus

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Improved wound appearance improved wound appearance by surface area measurement 8 weeks to 6 months
Primary improved wound appearance wound indentation measurement with caliper 8 weeks to 6 months
Primary improved wound appearance wound bulge measured with caliper 8 weeks to 6 months
Primary Modified Vancouver Scar Scale a scale of visual assessment of a scar 8 weeks to 6 months
Primary Manchester Scar Scale A new quantitative scale for clinical scar assessment 8 weeks to 6 months
See also
  Status Clinical Trial Phase
Withdrawn NCT00872638 - The Effect of Wound Edge Eversion on Cosmesis N/A
Completed NCT01835405 - LiquiBand Versus Dermabond Versus Sutures for Closure of Surgical Wounds N/A
Completed NCT00557947 - Prineo (Dermabond Protape) Versus Sutures for Full-thickness Surgical Incisions Phase 4
Completed NCT00890578 - HISTOACRYL: A Study of Its Efficacy in Final Scar Formation Phase 4